Figure 5.
Promotion of apoptosis in tumor cells by MSNs-loaded siRNAs. (A) Scheme of the preparation process of Vorinostat and cFLIP siRNA-coloaded mesoporous silica nanoparticles with pH-ultrasensitive valves (Vor/siR@MSN-PB-PEG) for suppression of cFLIP in cancer cells, Vor/siR@MSN-PB-PEG-inhibited cFLIP expression, and induced apoptosis caspase pathways in cancer cells; (B) EGFR-targeted (cetuximab) mesoporous silica nanoparticle (NP) platform for PLK1 siRNA (siPLK1) delivery or C-siPLK1-NP and proapoptotic effects of C-siPLK1-NP treatment on NSCLC (A549, H460) cell lines. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns = not statistically significant.
